A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and pharmacokinetic characteristics of
fixed-dose combination of MP-513 20mg and Metformin XR 1000mg with coadministration of the
two separate drugs in healthy male volunteers.